The heparin binding 25 kDa fragment of thrombospondin‐1 promotes angiogenesis and modulates gelatinase and TIMP‐2 production in endothelial cells

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The FASEB Journal

• Publication date

  2000-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1096/fj.99-0931fjePMID 10973914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

  1999cited by this paper
• Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization.

  1998cited by this paper
• Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis.

  1998cited by this paper
• Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.

  1998cited by this paper
• Isolation and characterization of human tumor-derived capillary endothelial cells: role of oncofetal fibronectin.

  1998cited by this paper
• Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF.

  1997cited by this paper
• CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells

  1997influential reference
• Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells.

  1997cited by this paper
• Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression.

  1997cited by this paper
• Interaction of platelet-derived growth factor with thrombospondin 1.

  1997influential reference
• Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia.

  1997cited by this paper
• Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells.

  1997influential reference
• Cellular Internalization and Degradation of Thrombospondin-1 Is Mediated by the Amino-terminal Heparin Binding Domain (HBD)

  1997cited by this paper
• The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.

  1997cited by this paper
• How tumors become angiogenic.

  1996cited by this paper
• Scatter factor binds to thrombospondin and other extracellular matrix components.

  1996influential reference
• Regulation of tumor growth and metastasis by thrombospondin‐1

  1996cited by this paper
• The role of thrombospondin-1 in tumor progression and angiogenesis.

  1996cited by this paper
• Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.

  1995cited by this paper
• Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis.

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1

  1995influential reference
• Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

  1994cited by this paper
• Matrix-bound thrombospondin promotes angiogenesis in vitro

  1994influential reference
• Plasma thrombospondin levels in patients with gynecologic malignancies

  1994cited by this paper
• Alterations in serum thrombospondin in patients with amyotrophic lateral sclerosis.

  1994cited by this paper
• Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines

  1994cited by this paper
• Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system.

  1994cited by this paper
• Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.

  1994cited by this paper
• Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

  1994cited by this paper
• Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2

  1994cited by this paper
• Thrombospondins.

  1994cited by this paper
• Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide.

  1993influential reference
• Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity.

  1993cited by this paper
• Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin‐binding domain and synthetic peptides from the type I repeats of thrombospondin

  1993influential reference
• Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase.

  1993cited by this paper
• Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.

  1993cited by this paper
• Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1.

  1993cited by this paper
• Thrombospondin 1 is a tight-binding competitive inhibitor of neutrophil cathepsin G. Determination of the kinetic mechanism of inhibition and localization of cathepsin G binding to the thrombospondin 1 type 3 repeats.

  1993cited by this paper
• Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

  1993influential reference
• Thrombospondin deposition in rat carotid artery injury.

  1990cited by this paper
• Physiology of thrombospondin.

  1990cited by this paper
• Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor

  1990cited by this paper
• Specific inhibition of endothelial cell proliferation by thrombospondin.

  1990cited by this paper
• A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

  1990influential reference
• Thrombospondin modulates focal adhesions in endothelial cells

  1989cited by this paper
• Thrombospondin in malignant and non-malignant breast tissue.

  1989cited by this paper
• Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

  1989cited by this paper
• Gangliosides promote the angiogenic response.

  1989cited by this paper
• Venular endothelial cells from bovine heart.

  1988cited by this paper
• Thrombospondin in early human wound tissue.

  1987cited by this paper
• Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells

  1987cited by this paper
• Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix.

  1983cited by this paper
• Angiogenesis and neoplastic progression in vitro.

  1982cited by this paper

• Studying Nitric Oxide in Endothelial Cells.

  2025cites this paper
• PP2A Affects Angiogenesis via Its Interaction with a Novel Phosphorylation Site of TSP1

  2024cites this paper
• Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis

  2024cites this paper
• Serum levels of matrix metalloproteinase 2 and its inhibitor after tonic-clonic seizures.

  2023cites this paper
• Homeostatic Regulation of Pro-Angiogenic and Anti-Angiogenic Proteins via Hedgehog, Notch Grid, and Ephrin Signaling in Tibial Dyschondroplasia

  2023cites this paper
• Controlled extracellular proteolysis of thrombospondins.

  2023cites this paper
• Insight on the cellular and molecular basis of blood vessel formation: A specific focus on tumor targets and therapy

  2023cites this paper
• Role of anti-angiogenic factors in the pathogenesis of breast cancer: A review of therapeutic potential.

  2022cites this paper
• Introduction

  2022cites this paper
• Studying Angiogenesis in the Rabbit Corneal Pocket Assay.

  2021cites this paper
• Endothelial Cell Behavior Is Determined by Receptor Clustering Induced by Thrombospondin-1

  2021cites this paper
• Calreticulin

  2020cites this paper
• Remodeling of the interstitial extracellular matrix in white matter multiple sclerosis lesions: Implications for remyelination (failure)

  2020cites this paper
• Artemisinin inhibits angiogenesis by regulating p38 MAPK/CREB/TSP‐1 signaling pathway in osteosarcoma

  2019cites this paper
• Thrombospondin-1 at the crossroads of corpus luteum fate decisions.

  2019cites this paper
• Manifestation of Pathological States of Numerous Diseases in the Largest Organ of the Human Body: (I) Basics and the Diseases of Tendon

  2019cites this paper
• Neutrophil-Mediated Proteolysis of Thrombospondin-1 Promotes Platelet Adhesion and String Formation

  2018cites this paper
• Targeting Difficult Protein-Protein Interactions with Plain and General Computational Approaches

  2018cites this paper
• N-Terminomics identifies HtrA1 cleavage of thrombospondin-1 with generation of a proangiogenic fragment in the polarized retinal pigment epithelial cell model of age-related macular degeneration.

  2018cites this paper
• Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis

  2018cites this paper
• Matricellular proteins in cancer: a focus on secreted Frizzled-related proteins

  2017cites this paper
• Thrombospondin-1 is a multifaceted player in tumor progression

  2017cites this paper
• Proteomic analysis of the endometrium during early pregnancy in the domestic pig.

  2017cites this paper
• Thrombospondin-1 is a multifaceted player in tumor progression.

  2017cites this paper
• High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice.

  2017cites this paper
• The Rabbit Corneal Pocket Assay.

  2016cites this paper
• Prostate Cancer-Associated Kallikrein-Related Peptidase 4 Activates Matrix Metalloproteinase-1 and Thrombospondin-1.

  2016cites this paper
• Angiogenesis Protocols

  2016cites this paper
• Development and characterization of an in vitro model of colorectal adenocarcinoma with MDR phenotype

  2016cites this paper
• ADAMTS13 and Angiogenesis

  2015cites this paper
• The corneal pocket assay.

  2015cites this paper
• Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts

  2015cites this paper
• ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2

  2014cites this paper
• Intermittent whole-body vibration attenuates a reduction in the number of the capillaries in unloaded rat skeletal muscle

  2014cites this paper
• Monoclonal antibodies to murine thrombospondin-1 and thrombospondin-2 reveal differential expression patterns in cancer and low antigen expression in normal tissues.

  2014cites this paper
• The Effects of Heparin Binding Proteins in Platelet Releasate on Bone Formation

  2014cites this paper
• Current understanding of the thrombospondin-1 interactome.

  2014cites this paper
• Mécanismes de progression des carcinomes de la prostate et recherche de nouveaux facteurs pronostiques

  2013cites this paper
• The role of thrombospondin-1 in cardiovascular health and pathology.

  2013cites this paper
• TP53 Status is Associated with Thrombospondin1 Expression In vitro

  2013cites this paper
• The recombinant lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigen.

  2012cites this paper
• The Textbook of Angiogenesis and Lymphangiogenesis: Methods and Applications

  2012cites this paper
• A motif within the N-terminal domain of TSP-1 specifically promotes the proangiogenic activity of endothelial colony-forming cells.

  2012cites this paper
• Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.

  2012cites this paper
• Rôle de la thrombospondine-1 dans la migration, l’invasion et la dissémination métastatique dans les carcinomes prostatiques et mammaires

  2012cites this paper
• Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells

  2012cites this paper
• In search of new prognostic molecular markers in ovarian cancer

  2012cites this paper
• ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesis.

  2012cites this paper
• Targeting angiogenesis with compounds from the extracellular matrix.

  2011cites this paper
• BMP-4 expression has prognostic significance in advanced serous ovarian carcinoma and is affected by cisplatin in OVCAR-3 cells

  2011cites this paper
• The role of histidine-rich glycoprotein in necrotic cell clearance and regulation of degradative enzymes

  2011cites this paper
• Mapping pro‐ and antiangiogenic factors on the surface of prostasomes of normal and malignant cell origin

  2010cites this paper
• Potential Relevance of Bell-Shaped and U-Shaped Dose-Responses for the Therapeutic Targeting of Angiogenesis in Cancer

  2010cites this paper
• Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors

  2010cites this paper
• Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action

  2010cites this paper
• Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer.

  2010cites this paper
• Biological activities and molecular interactions of the C-terminal residue of thrombospondin-4, an epitome of acidic amphipathic peptides.

  2010cites this paper
• The corneal pocket assay.

  2009cites this paper
• The N-Terminal Domain of Thrombospondin-1: a Key for the Dual Effect of TSP-1 in Angiogenesis and Cancer Progression?

  2009cites this paper
• Thrombospondins function as regulators of angiogenesis

  2009influential citation
• Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies

  2009cites this paper
• Thrombospondins in the heart: potential functions in cardiac remodeling

  2009cites this paper
• Estrogen regulation of thrombospondin‐1 in human breast cancer cells

  2009cites this paper
• Endogenous inhibitors of angiogenesis: a historical review.

  2009cites this paper
• Syndecan‐4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro‐angiogenic N‐terminal domain of thrombospondin‐1

  2008cites this paper
• Differential involvement of TGF-beta1 in mediating the motogenic effects of TSP-1 on endothelial cells, fibroblasts and oral tumour cells.

  2008cites this paper
• Thrombospondin-1 enhances human thyroid carcinoma cell invasion through urokinase activity.

  2008cites this paper
• Thrombospondin-1 expression correlates with angiogenesis in experimental cirrhosis.

  2008cites this paper
• Thrombospondins: from structure to therapeutics

  2008cites this paper
• Collagen-binding domains of gelatinase A and thrombospondin-derived peptides impede endocytic clearance of active gelatinase A and promote HT1080 fibrosarcoma cell invasion.

  2008cites this paper
• Expression von MMP-1, -2, -3 und Emmprin in oralen/oropharyngealen Plattenepithelkarzinomen

  2008cites this paper
• Gene Expression Changes in the Skin of Rats Induced by Prolonged 35 GHz Millimeter-Wave Exposure

  2008cites this paper
• Thrombospondins: Endogenous Inhibitors of Angiogenesis

  2008cites this paper
• Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.

  2008cites this paper
• Heparin-induced cis- and trans-Dimerization Modes of the Thrombospondin-1 N-terminal Domain*

  2008cites this paper
• EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways

  2007cites this paper
• Interaction of &agr;9&bgr;1 Integrin With Thrombospondin-1 Promotes Angiogenesis

  2007cites this paper
• Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation.

  2007cites this paper
• Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis.

  2007cites this paper
• The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains

  2007cites this paper
• Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study.

  2007influential citation
• Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation

  2006cites this paper
• Receptor communication within the lymphocyte plasma membrane: a role for the thrombospondin family of matricellular proteins

  2006cites this paper
• Regulation of tumor angiogenesis by thrombospondin-1.

  2006cites this paper
• Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue

  2006cites this paper
• Type I collagen is a molecular target for inhibition of angiogenesis by endogenous thrombospondin-1

  2006cites this paper
• Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo.

  2006cites this paper
• Extraction of RNA from archival tissues and measurement of thrombospondin-1 mRNA in normal, dysplastic, and malignant oral tissues.

  2006cites this paper
• IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway.

  2006cites this paper
• Reduction of angiocidin expression in human umbilical vein endothelial cells via siRNA silencing inhibits angiogenesis.

  2006cites this paper
• Temporal thrombospondin-1 mRNA response in skeletal muscle exposed to acute and chronic exercise

  2006cites this paper
• Biological Therapies for Metastatic Breast Cancer: Antiangiogenesis

  2006cites this paper
• Expression of thrombospondin-1 is correlated with microvessel density in prostate cancer

  2006cites this paper
• The Effect of Epicatechin on the High Glucose-induced TSP-1 Expression and MMP-2 Activity in Rat Vascular Smooth Muscle Cells

  2006influential citation
• Interleukin-31: a new cytokine involved in inflammation of the skin.

  2006cites this paper
• Novel integrin antagonists derived from thrombospondins.

  2005cites this paper
• Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor.

  2005cites this paper
• Expression of Thrombospondin-1 in Resected Colorectal Liver Metastases Predicts Poor Prognosis

  2005cites this paper
• Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induce promyelocytic leukemia cell differentiation and apoptosis.

  2005cites this paper
• Proteome of endothelial cell‐derived procoagulant microparticles

  2005cites this paper